{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:35:09Z","timestamp":1791477309008,"version":"4.3.4"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00223-020-00665-8","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T14:03:02Z","timestamp":1580306582000},"page":"116-127","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Hyperphosphatemia and Chronic Kidney Disease: A Major Daily Concern Both in Adults and in Children"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0578-2529","authenticated-orcid":false,"given":"Justine","family":"Bacchetta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bernardor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corentin","family":"Naud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ranchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"issue":"4","key":"665_CR1","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1681\/ASN.2011111115","volume":"23","author":"MM Mitsnefes","year":"2012","unstructured":"Mitsnefes MM (2012) Cardiovascular disease in children with chronic kidney disease. J Am Soc Nephrol 23(4):578\u2013585","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"665_CR2","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s00467-012-2347-x","volume":"28","author":"R Shroff","year":"2013","unstructured":"Shroff R (2013) Phosphate is a vascular toxin. Pediatr Nephrol 28(4):583\u2013593","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"665_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1681\/ASN.2011121191","volume":"24","author":"R Shroff","year":"2013","unstructured":"Shroff R, Long DA, Shanahan C (2013) Mechanistic insights into vascular calcification in CKD. J Am Soc Nephrol 24(2):179\u2013189","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"665_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Dr\u00fceke T, Cunningham J, Goodman W, Martin K, Olgaard K et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 69(11):1945\u20131953","journal-title":"Kidney Int."},{"issue":"20","key":"665_CR5","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"WG Goodman","year":"2000","unstructured":"Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D et al (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 342(20):1478\u20131483","journal-title":"N Engl J Med."},{"issue":"1","key":"665_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","volume":"106","author":"J Oh","year":"2002","unstructured":"Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U et al (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106(1):100\u2013105","journal-title":"Circulation"},{"key":"665_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.bone.2014.03.048","volume":"64","author":"D Cejka","year":"2014","unstructured":"Cejka D, Weber M, Diarra D, Reiter T, Kainberger F, Haas M (2014) Inverse association between bone microarchitecture assessed by HR-pQCT and coronary artery calcification in patients with end-stage renal disease. Bone 64:33\u201338","journal-title":"Bone"},{"issue":"10","key":"665_CR8","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1681\/ASN.2014070686","volume":"26","author":"HH Malluche","year":"2015","unstructured":"Malluche HH, Blomquist G, Monier-Faugere M-C, Cantor TL, Davenport DL (2015) High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients on dialysis. J Am Soc Nephrol 26(10):2534\u20132544","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"665_CR9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00467-007-0733-6","volume":"23","author":"H Ziolkowska","year":"2008","unstructured":"Ziolkowska H, Brzewski M, Roszkowska-Blaim M (2008) Determinants of the intima-media thickness in children and adolescents with chronic kidney disease. Pediatr Nephrol. 23(5):805\u2013811","journal-title":"Pediatr Nephrol."},{"key":"665_CR10","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s00467-018-3978-3","volume":"33","author":"E Preka","year":"2018","unstructured":"Preka E, Ranchin B, Doyon A, Vierge M, Ginhoux T, Kassai B et al (2018) The interplay between bone and vessels in pediatric CKD: lessons from a single-center study. Pediatr Nephrol. 33:1565\u20131575","journal-title":"Pediatr Nephrol."},{"key":"665_CR11","first-page":"S1","volume":"113","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD\u2013MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD\u2013MBD). Kidney Int Supl 113:S1\u2013130","journal-title":"Kidney Int Supl"},{"issue":"1","key":"665_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","volume":"92","author":"M Ketteler","year":"2017","unstructured":"Ketteler M, Block GA, Evenepoel P, Fukagawa M, Herzog CA, McCann L et al (2017) Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD\u2013MBD) guideline update: what\u2019s changed and why it matters. Kidney Int 92(1):26\u201336","journal-title":"Kidney Int"},{"issue":"7","key":"665_CR13","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/ndt\/gfx080","volume":"32","author":"R Shroff","year":"2017","unstructured":"Shroff R, Wan M, Nagler EV, Bakkaloglu S, Cozzolino M, Bacchetta J et al (2017) Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2\u20135 and on dialysis. Nephrol Dial Transplant 32(7):1114\u20131127","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"665_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00467-005-2082-7","volume":"21","author":"G Klaus","year":"2006","unstructured":"Klaus G, Watson A, Edefonti A, Fischbach M, R\u00f6nnholm K, Schaefer F et al (2006) Prevention and treatment of renal osteodystrophy in children on chronic renal failure: European guidelines. Pediatr Nephrol 21(2):151\u2013159","journal-title":"Pediatr Nephrol"},{"issue":"9","key":"665_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41581-019-0161-4","volume":"15","author":"J Drube","year":"2019","unstructured":"Drube J, Wan M, Bonthuis M, W\u00fchl E, Bacchetta J, Santos F et al (2019) Clinical practice recommendations for growth hormone treatment in children with chronic kidney disease. Nat Rev Nephrol 15(9):577\u2013589","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"665_CR16","first-page":"49","volume":"109","author":"E Ritz","year":"2012","unstructured":"Ritz E, Hahn K, Ketteler M, Kuhlmann MK, Mann J (2012) Phosphate additives in food\u2013a health risk. Dtsch Arztebl Int 109(4):49\u201355","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"665_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3945\/ajcn.112.053934","volume":"98","author":"MS Calvo","year":"2013","unstructured":"Calvo MS, Uribarri J (2013) Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population. Am J Clin Nutr 98(1):6\u201315","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"665_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/81664","volume":"26","author":"ADHR Consortium","year":"2000","unstructured":"ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26(3):345\u2013348","journal-title":"Nat Genet"},{"issue":"12","key":"665_CR19","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.2011.47","volume":"79","author":"T Isakova","year":"2011","unstructured":"Isakova T, Wahl P, Vargas GS, Guti\u00e9rrez OM, Scialla J, Xie H et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79(12):1370\u20131378","journal-title":"Kidney Int"},{"issue":"6","key":"665_CR20","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Guti\u00e9rrez","year":"2008","unstructured":"Guti\u00e9rrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A et al (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359(6):584\u2013592","journal-title":"N Engl J Med"},{"issue":"1","key":"665_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.mce.2008.10.052","volume":"299","author":"H Kurosu","year":"2009","unstructured":"Kurosu H, Kuro-O M (2009) The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol Cell Endocrinol 299(1):72\u201378","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"665_CR22","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1359\/jbmr.080417","volume":"23","author":"Y Yamazaki","year":"2008","unstructured":"Yamazaki Y, Tamada T, Kasai N, Urakawa I, Aono Y, Hasegawa H et al (2008) Anti-FGF23 neutralizing antibodies show the physiological role and structural features of FGF23. J Bone Miner Res 23(9):1509\u20131518","journal-title":"J Bone Miner Res"},{"issue":"4","key":"665_CR23","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T et al (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113(4):561\u2013568","journal-title":"J Clin Invest"},{"issue":"12","key":"665_CR24","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M et al (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117(12):4003\u20134008","journal-title":"J Clin Invest"},{"issue":"11","key":"665_CR25","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.2215\/CJN.02110216","volume":"11","author":"AA Portale","year":"2016","unstructured":"Portale AA, Wolf MS, Messinger S, Perwad F, J\u00fcppner H, Warady BA et al (2016) Fibroblast growth factor 23 and risk of CKD progression in children. Clin J Am Soc Nephrol 11(11):1989\u20131998","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"665_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2215\/CJN.05940611","volume":"7","author":"K Wesseling-Perry","year":"2012","unstructured":"Wesseling-Perry K, Pereira RC, Tseng C-H, Elashoff R, Zaritsky JJ, Yadin O et al (2012) Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 7(1):146\u2013152","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"665_CR27","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/ki.2009.414","volume":"77","author":"H Komaba","year":"2010","unstructured":"Komaba H, Goto S, Fujii H, Hamada Y, Kobayashi A, Shibuya K et al (2010) Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 77(3):232\u2013238","journal-title":"Kidney Int"},{"key":"665_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.01.006","author":"J Bacchetta","year":"2019","unstructured":"Bacchetta J, Bardet C, Pri\u00e9 D (2019) Physiology of FGF23 and overview of genetic diseases associated with renal phosphate wasting. Metab Clin Exp. https:\/\/doi.org\/10.1016\/j.metabol.2019.01.006","journal-title":"Metab Clin Exp"},{"issue":"11","key":"665_CR29","doi-asserted-by":"publisher","first-page":"4393","DOI":"10.1172\/JCI46122","volume":"121","author":"C Faul","year":"2011","unstructured":"Faul C, Amaral AP, Oskouei B, Hu M-C, Sloan A, Isakova T et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121(11):4393\u20134408","journal-title":"J Clin Invest"},{"issue":"12","key":"665_CR30","doi-asserted-by":"publisher","first-page":"e1003975","DOI":"10.1371\/journal.pgen.1003975","volume":"9","author":"H Olauson","year":"2013","unstructured":"Olauson H, Lindberg K, Amin R, Sato T, Jia T, Goetz R et al (2013) Parathyroid-specific deletion of Klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion. PLoS Genet 9(12):e1003975","journal-title":"PLoS Genet"},{"issue":"1","key":"665_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/jbmr.1740","volume":"28","author":"J Bacchetta","year":"2013","unstructured":"Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B et al (2013) Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25-dihydroxyvitamin D in human monocytes. J Bone Miner Res 28(1):46\u201355","journal-title":"J Bone Miner Res"},{"issue":"1","key":"665_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1681\/ASN.2014101009","volume":"27","author":"M Chonchol","year":"2016","unstructured":"Chonchol M, Greene T, Zhang Y, Hoofnagle AN, Cheung AK (2016) Low Vitamin D and high fibroblast growth factor 23 serum levels associate with infectious and cardiac deaths in the HEMO study. J Am Soc Nephrol 27(1):227\u2013237","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"665_CR33","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/emmm.201303716","volume":"6","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova O, Slavic S, Smorodchenko A, Zeitz U, Shalhoub V, Lanske B et al (2014) FGF23 regulates renal sodium handling and blood pressure. EMBO Mol Med 6(6):744\u2013759","journal-title":"EMBO Mol Med"},{"issue":"5","key":"665_CR34","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jnc.13585","volume":"137","author":"N Hensel","year":"2016","unstructured":"Hensel N, Sch\u00f6n A, Konen T, L\u00fcbben V, F\u00f6rthmann B, Baron O et al (2016) Fibroblast growth factor 23 signaling in hippocampal cells: impact on neuronal morphology and synaptic density. J Neurochem 137(5):756\u2013769","journal-title":"J Neurochem"},{"issue":"9\u201310","key":"665_CR35","first-page":"645","volume":"24","author":"J Gardner","year":"2011","unstructured":"Gardner J, Ashraf A, You Z, McCormick K (2011) Changes in plasma FGF23 in growth hormone deficient children during rhGH therapy. J Pediatr Endocrinol Metab 24(9\u201310):645\u2013650","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"2","key":"665_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.kint.2016.09.016","volume":"91","author":"JM Rutkowski","year":"2017","unstructured":"Rutkowski JM, Pastor J, Sun K, Park SK, Bobulescu IA, Chen CT et al (2017) Adiponectin alters renal calcium and phosphate excretion through regulation of klotho expression. Kidney Int 91(2):324\u2013337","journal-title":"Kidney Int"},{"issue":"9","key":"665_CR37","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s00467-013-2493-9","volume":"28","author":"MR Denburg","year":"2013","unstructured":"Denburg MR, Kalkwarf HJ, de Boer IH, Hewison M, Shults J, Zemel BS et al (2013) Vitamin D bioavailability and catabolism in pediatric chronic kidney disease. Pediatr Nephrol 28(9):1843\u20131853","journal-title":"Pediatr Nephrol"},{"issue":"5","key":"665_CR38","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.kint.2016.05.019","volume":"90","author":"S Singh","year":"2016","unstructured":"Singh S, Grabner A, Yanucil C, Schramm K, Czaya B, Krick S et al (2016) Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney Int 90(5):985\u2013996","journal-title":"Kidney Int"},{"issue":"12","key":"665_CR39","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1681\/ASN.2016121350","volume":"28","author":"MF Eisenga","year":"2017","unstructured":"Eisenga MF, van Londen M, Leaf DE, Nolte IM, Navis G, Bakker SJL et al (2017) C-Terminal fibroblast growth factor 23, iron deficiency, and mortality in renal transplant recipients. J Am Soc Nephrol 28(12):3639\u20133646","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"665_CR40","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/jbmr.1923","volume":"28","author":"M Wolf","year":"2013","unstructured":"Wolf M, Koch TA, Bregman DB (2013) Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 28(8):1793\u20131803","journal-title":"J Bone Miner Res"},{"issue":"4","key":"665_CR41","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/sj.ki.5000394","volume":"70","author":"CS Ritter","year":"2006","unstructured":"Ritter CS, Armbrecht HJ, Slatopolsky E, Brown AJ (2006) 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Kidney Int 70(4):654\u2013659","journal-title":"Kidney Int"},{"issue":"2","key":"665_CR42","doi-asserted-by":"publisher","first-page":"216","DOI":"10.2215\/CJN.04760511","volume":"7","author":"R Shroff","year":"2012","unstructured":"Shroff R, Wan M, Gullett A, Ledermann S, Shute R, Knott C et al (2012) Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol 7(2):216\u2013223","journal-title":"Clin J Am Soc Nephrol"},{"key":"665_CR43","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/ndt\/gfx059","volume":"33","author":"P-A Westerberg","year":"2017","unstructured":"Westerberg P-A, Sterner G, Ljunggren \u00d6, Isaksson E, Elvarson F, Dezfoolian H et al (2017) High doses of cholecalciferol alleviate the progression of hyperparathyroidism in patients with CKD Stages 3\u20134: results of a 12-week double-blind, randomized, controlled study. Nephrol Dial Transplant 33:466\u2013471","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"665_CR44","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00467-018-3920-8","volume":"33","author":"E Snauwaert","year":"2018","unstructured":"Snauwaert E, Van Biesen W, Raes A, Glorieux G, Vanholder R, Vande Walle J et al (2018) A plea for more uremic toxin research in children with chronic kidney disease. Pediatr Nephrol 33(6):921\u2013924","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"665_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.mad.2010.02.008","volume":"131","author":"M Kuro-o","year":"2010","unstructured":"Kuro-o M (2010) A potential link between phosphate and aging\u2013lessons from Klotho-deficient mice. Mech Ageing Dev 131(4):270\u2013275","journal-title":"Mech Ageing Dev"},{"issue":"11","key":"665_CR46","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1681\/ASN.2010020221","volume":"21","author":"OM Guti\u00e9rrez","year":"2010","unstructured":"Guti\u00e9rrez OM, Anderson C, Isakova T, Scialla J, Negrea L, Anderson AH et al (2010) Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol 21(11):1953\u20131960","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"665_CR47","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/ki.2013.3","volume":"83","author":"JJ Scialla","year":"2013","unstructured":"Scialla JJ, Lau WL, Reilly MP, Isakova T, Yang H-Y, Crouthamel MH et al (2013) Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int 83(6):1159\u20131168","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"665_CR48","first-page":"584","volume":"5","author":"L Ardeshirpour","year":"2007","unstructured":"Ardeshirpour L, Cole DEC, Carpenter TO (2007) Evaluation of bone and mineral disorders. Pediatr Endocrinol Rev 5(Suppl 1):584\u2013598","journal-title":"Pediatr Endocrinol Rev"},{"issue":"3 Suppl 2","key":"665_CR49","first-page":"S11","volume":"53","author":"KDOQI Work Group","year":"2009","unstructured":"KDOQI Work Group (2009) KDOQI Clinical practice guideline for nutrition in children with CKD: 2008 update executive summary. Am J Kidney Dis 53(3 Suppl 2):S11\u2013104","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"665_CR50","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/ndt\/gfs404","volume":"28","author":"D Fouque","year":"2013","unstructured":"Fouque D, Roth H, Pelletier S, London GM, Hannedouche T, Jean G et al (2013) Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets? Nephrol Dial Transplant 28(2):360\u2013367","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"665_CR51","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/ndt\/gfp570","volume":"25","author":"C Rinat","year":"2010","unstructured":"Rinat C, Becker-Cohen R, Nir A, Feinstein S, Shemesh D, Algur N et al (2010) A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic renal failure. Nephrol Dial Transplant 25(3):785\u2013793","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"665_CR52","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.ki.5002406","volume":"72","author":"M Mizobuchi","year":"2007","unstructured":"Mizobuchi M, Finch JL, Martin DR, Slatopolsky E (2007) Differential effects of vitamin D receptor activators on vascular calcification in uremic rats. Kidney Int 72(6):709\u2013715","journal-title":"Kidney Int"},{"issue":"8","key":"665_CR53","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15(8):2208\u20132218","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"665_CR54","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1681\/ASN.2008020141","volume":"20","author":"RN Foley","year":"2009","unstructured":"Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA (2009) Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20(2):397\u2013404","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"665_CR55","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/archinte.167.9.879","volume":"167","author":"R Dhingra","year":"2007","unstructured":"Dhingra R, Sullivan LM, Fox CS, Wang TJ, D\u2019Agostino RB, Gaziano JM et al (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167(9):879\u2013885","journal-title":"Arch Intern Med"},{"issue":"11","key":"665_CR56","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1681\/ASN.2006121397","volume":"18","author":"RC Shroff","year":"2007","unstructured":"Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D et al (2007) Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol 18(11):2996\u20133003","journal-title":"J Am Soc Nephrol"},{"key":"665_CR57","doi-asserted-by":"publisher","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","volume":"3","author":"M Mannstadt","year":"2017","unstructured":"Mannstadt M, Bilezikian JP, Thakker RV, Hannan FM, Clarke BL, Rejnmark L et al (2017) Hypoparathyroidism. Nat Rev Dis Primers 3:17055","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"665_CR58","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","volume":"14","author":"G Mantovani","year":"2018","unstructured":"Mantovani G, Bastepe M, Monk D, de Sanctis L, Thiele S, Usardi A et al (2018) Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol 14(8):476\u2013500","journal-title":"Nat Rev Endocrinol"},{"issue":"6","key":"665_CR59","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ng1358","volume":"36","author":"O Topaz","year":"2004","unstructured":"Topaz O, Shurman DL, Bergman R, Indelman M, Ratajczak P, Mizrachi M et al (2004) Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 36(6):579\u2013581","journal-title":"Nat Genet"},{"issue":"7","key":"665_CR60","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00467-018-3945-z","volume":"33","author":"D Claramunt-Taberner","year":"2018","unstructured":"Claramunt-Taberner D, Bertholet-Thomas A, Carlier M-C, Dijoud F, Chotel F, Silve C et al (2018) Hyperphosphatemic tumoral calcinosis caused by FGF23 compound heterozygous mutations: what are the therapeutic options for a better control of phosphatemia? Pediatr Nephrol 33(7):1263\u20131267","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"665_CR61","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3945\/ajcn.113.073148","volume":"99","author":"AR Chang","year":"2014","unstructured":"Chang AR, Lazo M, Appel LJ, Guti\u00e9rrez OM, Grams ME (2014) High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III. Am J Clin Nutr 99(2):320\u2013327","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"665_CR62","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1053\/j.ajkd.2013.04.013","volume":"62","author":"EJ Weinman","year":"2013","unstructured":"Weinman EJ, Light PD, Suki WN (2013) Gastrointestinal phosphate handling in CKD and its association with cardiovascular disease. Am J Kidney Dis 62(5):1006\u20131011","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"665_CR63","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1053\/j.ajkd.2017.04.022","volume":"70","author":"P Khairallah","year":"2017","unstructured":"Khairallah P, Isakova T, Asplin J, Hamm L, Dobre M, Rahman M et al (2017) Acid Load and Phosphorus Homeostasis in CKD. Am J Kidney Dis 70(4):541\u2013550","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"665_CR64","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1093\/ndt\/gfx065","volume":"32","author":"R Shroff","year":"2017","unstructured":"Shroff R, Wan M, Nagler EV, Bakkaloglu S, Fischer D-C, Bishop N et al (2017) Clinical practice recommendations for native vitamin D therapy in children with chronic kidney disease Stages 2\u20135 and on dialysis. Nephrol Dial Transplant 32(7):1098\u20131113","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"665_CR65","first-page":"47","volume":"35","author":"J Bacchetta","year":"2019","unstructured":"Bacchetta J, Schmitt CP, Ariceta G, Bakkaloglu SA, Groothoff J, Wan M et al (2019) Cinacalcet use in paediatric dialysis: a position statement from the European Society for Paediatric Nephrology and the Chronic Kidney Disease-Mineral and Bone Disorders Working Group of the ERA-EDTA. Nephrol Dial Transplant 35(1):47\u201364","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"665_CR66","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1210\/jc.2012-4188","volume":"98","author":"MR Denburg","year":"2013","unstructured":"Denburg MR, Tsampalieros AK, de Boer IH, Shults J, Kalkwarf HJ, Zemel BS et al (2013) Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease. J Clin Endocrinol Metab 98(5):1930\u20131938","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"665_CR67","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.2215\/CJN.01330210","volume":"5","author":"SA Bakkaloglu","year":"2010","unstructured":"Bakkaloglu SA, Wesseling-Perry K, Pereira RC, Gales B, Wang H-J, Elashoff RM et al (2010) Value of the new bone classification system in pediatric renal osteodystrophy. Clin J Am Soc Nephrol 5(10):1860\u20131866","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"665_CR68","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1681\/ASN.2015020152","volume":"27","author":"MR Denburg","year":"2016","unstructured":"Denburg MR, Kumar J, Jemielita T, Brooks ER, Skversky A, Portale AA et al (2016) Fracture Burden and Risk Factors in Childhood CKD: Results from the CKiD Cohort Study. J Am Soc Nephrol 27(2):543\u2013550","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"665_CR69","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1359\/jbmr.2000.15.11.2245","volume":"15","author":"DA Bailey","year":"2000","unstructured":"Bailey DA, Martin AD, McKay HA, Whiting S, Mirwald R (2000) Calcium accretion in girls and boys during puberty: a longitudinal analysis. J Bone Miner Res 15(11):2245\u20132250","journal-title":"J Bone Miner Res"},{"key":"665_CR70","first-page":"CD008327","volume":"11","author":"D Hahn","year":"2015","unstructured":"Hahn D, Hodson EM, Craig JC (2015) Interventions for metabolic bone disease in children with chronic kidney disease. Cochrane Database Syst Rev 11:CD008327","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"665_CR71","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1177\/2168479015592194","volume":"49","author":"RA Sherman","year":"2015","unstructured":"Sherman RA, Ravella S, Kapoian T (2015) The phosphate content of prescription medication: a new consideration. Ther Innov Regul Sci 49(6):886\u2013889","journal-title":"Ther Innov Regul Sci"},{"issue":"6","key":"665_CR72","doi-asserted-by":"publisher","first-page":"6S17","DOI":"10.1016\/S1769-7255(18)30647-3","volume":"14","author":"T Hannedouche","year":"2018","unstructured":"Hannedouche T, Fouque D, Joly D (2018) Metabolic complications in chronic kidney disease: hyperphosphatemia, hyperkalemia and anemia. Nephrol Ther 14(6):6S17\u201316S25","journal-title":"Nephrol Ther"},{"issue":"2","key":"665_CR73","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2215\/CJN.05040610","volume":"6","author":"SM Moe","year":"2011","unstructured":"Moe SM, Zidehsarai MP, Chambers MA, Jackman LA, Radcliffe JS, Trevino LL et al (2011) Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease. Clin J Am Soc Nephrol 6(2):257\u2013264","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"665_CR74","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1053\/j.jrn.2012.01.026","volume":"22","author":"JJ Scialla","year":"2012","unstructured":"Scialla JJ, Appel LJ, Wolf M, Yang W, Zhang X, Sozio SM et al (2012) Plant protein intake is associated with fibroblast growth factor 23 and serum bicarbonate levels in patients with chronic kidney disease: the chronic renal insufficiency cohort study. J Ren Nutr 22(4):379\u2013388.e1","journal-title":"J Ren Nutr"},{"issue":"6","key":"665_CR75","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1001\/jama.2009.96","volume":"301","author":"C Sullivan","year":"2009","unstructured":"Sullivan C, Sayre SS, Leon JB, Machekano R, Love TE, Porter D et al (2009) Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 301(6):629\u2013635","journal-title":"JAMA"},{"key":"665_CR76","first-page":"CD010350","volume":"9","author":"Z Liu","year":"2015","unstructured":"Liu Z, Su G, Guo X, Wu Y, Liu X, Zou C et al (2015) Dietary interventions for mineral and bone disorder in people with chronic kidney disease. Cochrane Database Syst Rev 9:CD010350","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"665_CR77","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/j.jrn.2007.05.008","volume":"17","author":"CM Sullivan","year":"2007","unstructured":"Sullivan CM, Leon JB, Sehgal AR (2007) Phosphorus-containing food additives and the accuracy of nutrient databases: implications for renal patients. J Ren Nutr 17(5):350\u2013354","journal-title":"J Ren Nutr"},{"issue":"6","key":"665_CR78","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1053\/j.jrn.2014.07.002","volume":"24","author":"E Lindley","year":"2014","unstructured":"Lindley E, Costelloe S, Bosomworth M, Fouque D, Freeman J, Keane D et al (2014) Use of a standard urine assay for measuring the phosphate content of beverages. J Ren Nutr 24(6):353\u2013356","journal-title":"J Ren Nutr"},{"key":"665_CR79","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2369-16-9","volume":"16","author":"C D\u2019Alessandro","year":"2015","unstructured":"D\u2019Alessandro C, Piccoli GB, Cupisti A (2015) The, \u201cphosphorus pyramid\u201d: a visual tool for dietary phosphate management in dialysis and CKD patients. BMC Nephrol 16:9","journal-title":"BMC Nephrol"},{"issue":"2","key":"665_CR80","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1681\/ASN.2008060609","volume":"20","author":"T Isakova","year":"2009","unstructured":"Isakova T, Guti\u00e9rrez OM, Chang Y, Shah A, Tamez H, Smith K et al (2009) Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20(2):388\u2013396","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"665_CR81","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00467-009-1328-1","volume":"25","author":"E Gonzalez","year":"2010","unstructured":"Gonzalez E, Schomberg J, Amin N, Salusky IB, Zaritsky J (2010) Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients. Pediatr Nephrol 25(2):373\u2013375","journal-title":"Pediatr Nephrol"},{"issue":"12","key":"665_CR82","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1007\/s00221-017-5102-5","volume":"235","author":"C Jin","year":"2017","unstructured":"Jin C, Gao L, Li Y, Wu S, Lu X, Yang J et al (2017) Lanthanum damages learning and memory and suppresses astrocyte-neuron lactate shuttle in rat hippocampus. Exp Brain Res 235(12):3817\u20133832","journal-title":"Exp Brain Res"},{"issue":"6","key":"665_CR83","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/ndt\/gfv006","volume":"30","author":"J Floege","year":"2015","unstructured":"Floege J, Covic AC, Ketteler M, Mann JFE, Rastogi A, Spinowitz B et al (2015) Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients. Nephrol Dial Transplant 30(6):1037\u20131046","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"665_CR84","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1007\/s00467-018-3999-y","volume":"33","author":"MR Hanudel","year":"2018","unstructured":"Hanudel MR, Laster M, Ramos G, Gales B, Salusky IB (2018) Clinical experience with the use of ferric citrate as a phosphate binder in pediatric dialysis patients. Pediatr Nephrol 33(11):2137\u20132142","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"665_CR85","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1159\/000487856","volume":"47","author":"K Kalantar-Zadeh","year":"2018","unstructured":"Kalantar-Zadeh K, Parameswaran V, Ficociello LH, Anderson L, Ofsthun NJ, Kwoh C et al (2018) Real-world scenario improvements in serum phosphorus levels and pill burden in peritoneal dialysis patients treated with sucroferric oxyhydroxide. Am J Nephrol 47(3):153\u2013161","journal-title":"Am J Nephrol"},{"issue":"6","key":"665_CR86","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1681\/ASN.2018101058","volume":"30","author":"JH Ix","year":"2019","unstructured":"Ix JH, Isakova T, Larive B, Raphael KL, Raj DS, Cheung AK et al (2019) Effects of nicotinamide and lanthanum carbonate on serum phosphate and fibroblast growth factor-23 in CKD: the COMBINE Trial. J Am Soc Nephrol 30(6):1096\u20131108","journal-title":"J Am Soc Nephrol"},{"key":"665_CR87","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-019-00689-w","author":"J Floege","year":"2019","unstructured":"Floege J (2019) Phosphate binders in chronic kidney disease: an updated narrative review of recent data. J Nephrol. https:\/\/doi.org\/10.1007\/s40620-019-00689-w","journal-title":"J Nephrol."},{"issue":"1","key":"665_CR88","first-page":"65","volume":"35","author":"N Kaesler","year":"2019","unstructured":"Kaesler N, Goettsch C, Weis D, Schurgers L, Hellmann B, Floege J et al (2019) Magnesium but not nicotinamide prevents vascular calcification in experimental uraemia. Nephrol Dial Transplant 35(1):65\u201373","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"665_CR89","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1525-139X.2011.00849.x","volume":"24","author":"Daugirdas JT, Finn WF, Emmett M, Chertow GM, Frequent Hemodialysis Network Trial Group","year":"2011","unstructured":"Daugirdas JT, Finn WF, Emmett M, Chertow GM, Frequent Hemodialysis Network Trial Group (2011) The phosphate binder equivalent dose. Semin Dial 24(1):41\u201349","journal-title":"Semin Dial"},{"issue":"3","key":"665_CR90","doi-asserted-by":"publisher","first-page":"e0120856","DOI":"10.1371\/journal.pone.0120856","volume":"10","author":"RC Pereira","year":"2015","unstructured":"Pereira RC, J\u00fcppner H, Gales B, Salusky IB, Wesseling-Perry K (2015) Osteocytic protein expression response to doxercalciferol therapy in pediatric dialysis patients. PLoS ONE 10(3):e0120856","journal-title":"PLoS ONE"},{"issue":"1","key":"665_CR91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","volume":"132","author":"SM Moe","year":"2015","unstructured":"Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R et al (2015) Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the evaluation of cinacalcet HCl therapy to lower cardiovascular events (EVOLVE) trial. Circulation 132(1):27\u201339","journal-title":"Circulation"},{"issue":"2","key":"665_CR92","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2215\/CJN.05420709","volume":"5","author":"RB Oliveira","year":"2010","unstructured":"Oliveira RB, Cancela ALE, Graciolli FG, Dos Reis LM, Draibe SA, Cuppari L et al (2010) Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD\u2013MBD therapy? Clin J Am Soc Nephrol 5(2):286\u2013291","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"665_CR93","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.2215\/CJN.03030317","volume":"12","author":"S Liabeuf","year":"2017","unstructured":"Liabeuf S, Ryckelynck J-P, El Esper N, Ure\u00f1a P, Combe C, Dussol B et al (2017) Randomized clinical trial of sevelamer carbonate on serum klotho and fibroblast growth factor 23 in CKD. Clin J Am Soc Nephrol 12(12):1930\u20131940","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"665_CR94","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000440968","volume":"131","author":"A Iguchi","year":"2015","unstructured":"Iguchi A, Kazama JJ, Yamamoto S, Yoshita K, Watanabe Y, Iino N et al (2015) Administration of ferric citrate hydrate decreases circulating FGF23 levels independently of serum phosphate levels in hemodialysis patients with iron deficiency. Nephron 131(3):161\u2013166","journal-title":"Nephron"},{"issue":"7","key":"665_CR95","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/ndt\/gfy127","volume":"34","author":"M Ketteler","year":"2019","unstructured":"Ketteler M, Sprague SM, Covic AC, Rastogi A, Spinowitz B, Rakov V et al (2019) Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients. Nephrol Dial Transplant 34(7):1163\u20131170","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"665_CR96","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1056\/NEJMra1301564","volume":"369","author":"P Cochat","year":"2013","unstructured":"Cochat P, Rumsby G (2013) Primary hyperoxaluria. N Engl J Med 369(7):649\u2013658","journal-title":"N Engl J Med"},{"issue":"6","key":"665_CR97","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3945\/ajcn.2008.26665","volume":"88","author":"CS Shinaberger","year":"2008","unstructured":"Shinaberger CS, Greenland S, Kopple JD, Van Wyck D, Mehrotra R, Kovesdy CP et al (2008) Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 88(6):1511\u20131518","journal-title":"Am J Clin Nutr"},{"key":"665_CR98","first-page":"493","volume":"5","author":"J Bacchetta","year":"2019","unstructured":"Bacchetta J (2019) Treatment of hyperphosphatemia: the dangers of high PTH levels. Pediatr Nephrol 5:493\u2013500","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"665_CR99","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ndt\/gfq713","volume":"26","author":"S Pelletier","year":"2011","unstructured":"Pelletier S, Fouque D (2011) Mineral and bone metabolism in dialysis: towards unified patient care? Nephrol Dial Transplant 26(1):7\u20139","journal-title":"Nephrol Dial Transplant"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00665-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-020-00665-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00665-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T19:23:01Z","timestamp":1611775381000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-020-00665-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00665-8","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]},"assertion":[{"value":"21 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Justine Bacchetta, Julie Bernardor, Charlotte Garnier, Corentin Naud, and Bruno Ranchin declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}